Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance-Reference-Cited by-同舟云学术

Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance

Published:2024-06 Issue:6 Volume:54 Page:1017-1030
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Lasica Masa¹²^ORCID,Anderson Mary A.³⁴,Boussioutas Alex⁵⁶⁷⁸,Gregory Gareth P.⁹¹⁰^ORCID,Hamad Nada¹¹^ORCID,Manos Kate¹²,McKelvie Penny¹³,Ng Michael¹⁴,Campbell Belinda¹⁵¹⁶¹⁷,Palfreyman Emma¹⁸,Salvaris Ross¹⁹²⁰^ORCID,Weinkove Robert²¹²²²³,Wight Joel²⁴²⁵,Opat Stephen¹⁰²⁶,Tam Constantine²⁷²⁸^ORCID

Affiliation:

1. Department of Clinical Haematology St Vincent's Hospital Melbourne Victoria Australia

2. The University of Melbourne Melbourne Victoria Australia

3. Department of Clinical Haematology Royal Melbourne Hospital and The Peter MacCallum Cancer Centre Melbourne Victoria Australia

4. Division of Blood Cells and Blood Cancer Walter and Eliza Hall Institute Melbourne Victoria Australia

5. Department of Gastroenterology Alfred Health Melbourne Victoria Australia

6. Monash University Melbourne Victoria Australia

7. The Alfred Melbourne Victoria Australia

8. Familial Cancer Clinic Peter MacCallum Cancer Centre Melbourne Victoria Australia

9. Clinical Sciences at Monash Health Monash University Melbourne Victoria Australia

10. Monash Haematology, Monash Health Melbourne Victoria Australia

11. Department of Haematology St Vincent's Hospital Sydney New South Wales Australia

12. Department of Haematology Flinders Medical Centre Adelaide South Australia Australia

13. Department of Anatomical Pathology St Vincent's Hospital Melbourne Victoria Australia

14. GenesisCare St Vincent's Hospital Melbourne Victoria Australia

15. Department of Radiation Oncology Peter MacCallum Cancer Centre Melbourne Victoria Australia

16. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Victoria Australia

17. Department of Clinical Pathology University of Melbourne Melbourne Victoria Australia

18. Department of Haematology Royal Darwin Hospital Darwin Northern Territory Australia

19. Department of Haematology Sir Charles Gairdner Hospital Perth Western Australia Australia

20. School of Medicine University of Western Australia Perth Western Australia Australia

21. Te Rerenga Ora Blood & Cancer Centre Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley Wellington New Zealand

22. Cancer Immunotherapy Programme Malaghan Institute of Medical Research Wellington New Zealand

23. Department of Pathology and Molecular Medicine University of Otago Wellington Wellington New Zealand

24. Department of Haematology and Bone Marrow Transplantation Townsville University Hospital Townsville Queensland Australia

25. School of Medicine James Cook University Townsville Queensland Australia

26. School of Clinical Sciences at Monash Health Monash University Melbourne Victoria Australia

27. Haematology Department Alfred Hospital Melbourne Victoria Australia

28. Central Clinical School Monash University Melbourne Victoria Australia

Abstract

AbstractMarginal zone lymphomas (MZLs) are a rare, indolent group of non‐Hodgkin lymphomas with different diagnostic, genetic and clinical features and therapeutic implications. The most common is extranodal MZL of mucosa‐associated lymphoid tissue, followed by splenic MZL and nodal MZL. Patients with MZL generally have good outcomes with long survival rates but frequently have a relapsing/remitting course requiring several lines of therapy. The heterogeneous presentation and relapsing course present the clinician with several diagnostic and therapeutic challenges. This position statement presents evidence‐based recommendations in the setting of Australia and New Zealand.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16390

Reference114 articles.

1. Incidence of marginal zone lymphoma in the United States, 2001‐2009 with a focus on primary anatomic site;Khalil MO;Br J Haematol,2014

2. The WHO classification of haematolymphoid tumours;Cree IA;Leukemia,2022

3. Unpublished Data. LaRDRL. 2023. Available from URL:https://lardr.org.

4. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

5. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow SH;Blood,2016